Release Date: 31/01/12 15:00 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 97.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%